# TRANSCAT, INC. (TRNS) · Edgar & Edgarette company card

> Transcat (TRNS) grew revenue 19.2% in FY2026 to $332 million, operating margin 4.0% against a 12.5% median for instruments for meas & testing of  electricity & elec signals, equity 62.6% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 99302 · fiscal year ended 2026-03-28 · 5 audited years read · [page](https://www.pops4.com/boards/company/TRNS) · [JSON](https://www.pops4.com/boards/company/TRNS.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $332M |
| Revenue growth, 1 year | 19.2% |
| Revenue growth per year | 12.8% |
| Operating margin | 4.0% (prior year 6.4%) |
| Net margin | 1.6% |
| Operating cash flow | $35M |
| Capital spending | $15M |
| Free cash flow | $20M |
| Cash | $5M |
| Long-term debt | $100M |
| Total assets | $480M |
| Total equity | $301M |
| Equity ÷ assets | 62.6% |
| Return on equity | 1.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 3.32 (safe zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -2.88 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow later · growing fast, and already turning revenue into cash

## Edgarette's reading

Exposure: revenue $331.9M (FY2026), total debt $99.9M. Experience: revenue up 19.2% on the year, up 12.8% a year over 4 years; operating margin 4.0%, down from 6.4%. Soundness: equity 62.6% of assets, return on equity 1.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $334.0M and $426.2M next year (method v4.1: its own 5-year record of growth weighed at 57% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $314.0M to $454.4M. A statistical range, not company guidance. Against peers (41 filers, $50M+ revenue, its industry group): operating margin 4.0% against a 12.5% median; growth 19.2% against 3.8%.

Range logged 2026-09-27, receipt 974e6cefb6d52f63, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-05-19 ([filing](https://www.sec.gov/Archives/edgar/data/99302/000120677426000287/0001206774-26-000287-index.htm))

## Recent filings

- 10-Q · filed 2026-11-03 · [filing](https://www.sec.gov/Archives/edgar/data/99302/000162828026069462/0001628280-26-069462-index.htm)
- 8-K · filed 2026-11-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/99302/000162828026069453/0001628280-26-069453-index.htm)
- 8-K · filed 2026-09-10 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/99302/000162828026061346/0001628280-26-061346-index.htm)
- 10-Q · filed 2026-08-04 · [filing](https://www.sec.gov/Archives/edgar/data/99302/000162828026052738/0001628280-26-052738-index.htm)
- 8-K · filed 2026-08-04 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/99302/000162828026052553/0001628280-26-052553-index.htm)
- DEF 14A · filed 2026-07-23 · [filing](https://www.sec.gov/Archives/edgar/data/99302/000114036126029371/0001140361-26-029371-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000099302.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=99302

## Cite

POPS4, Edgar & Edgarette: TRANSCAT, INC. (TRNS) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/TRNS. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.